Cargando…

Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review

Background and Objectives: Post-traumatic stress disorder (PTSD) is a common psychiatric disorder resulting from a traumatic event, is manifested through hyperarousal, anxiety, depressive symptoms, and sleep disturbances. Despite several therapeutic approaches being available, both pharmacological a...

Descripción completa

Detalles Bibliográficos
Autores principales: Orsolini, Laura, Chiappini, Stefania, Volpe, Umberto, De Berardis, Domenico, Latini, Roberto, Papanti, Gabriele Duccio, Corkery, John Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780141/
https://www.ncbi.nlm.nih.gov/pubmed/31450833
http://dx.doi.org/10.3390/medicina55090525
_version_ 1783457059235168256
author Orsolini, Laura
Chiappini, Stefania
Volpe, Umberto
De Berardis, Domenico
Latini, Roberto
Papanti, Gabriele Duccio
Corkery, John Martin
author_facet Orsolini, Laura
Chiappini, Stefania
Volpe, Umberto
De Berardis, Domenico
Latini, Roberto
Papanti, Gabriele Duccio
Corkery, John Martin
author_sort Orsolini, Laura
collection PubMed
description Background and Objectives: Post-traumatic stress disorder (PTSD) is a common psychiatric disorder resulting from a traumatic event, is manifested through hyperarousal, anxiety, depressive symptoms, and sleep disturbances. Despite several therapeutic approaches being available, both pharmacological and psychological, recently a growing interest has developed in using cannabis and synthetic cannabinoids stems from their consideration as more efficient and better tolerated alternatives for the treatment of this condition. The present paper aims to evaluate the clinical and therapeutic potentials of medical cannabis and synthetic cannabinoids in treating PTSD patients. Methods: A systematic electronic search was performed, including all papers published up to May 2019, using the following keywords (((cannabis[Title/Abstract]) OR (synthetic cannabinoids [Title/Abstract])) AND ((PTSD[Title/Abstract]) OR (Posttraumatic stress disorder[Title/Abstract]))) for the topics ‘Cannabis’, ‘Synthetic Cannabinoids’, ‘PTSD’, and MESH terms, on the PubMed, Cochrane Library, and Web of Science online databases. For data gathering purposes, PRISMA guidelines were followed. Results were organized into two groups, considering cannabis and synthetic cannabinoids as different therapeutic approaches for PTSD. Results: Present data show that cannabis and synthetic cannabinoids, both acting on the endocannabinoids system, may have a potential therapeutic use for improving PTSD symptoms, e.g., reducing anxiety, modulating memory-related processes, and improving sleep. Conclusions: Even though the current literature suggests that cannabis and synthetic cannabinoids may have a role in the treatment of PTSD, there is currently limited evidence regarding their safety and efficacy. Therefore, additional research is needed in order to better understand the effectiveness and therapeutic usage of these drug classes and monitor their safety.
format Online
Article
Text
id pubmed-6780141
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67801412019-10-30 Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review Orsolini, Laura Chiappini, Stefania Volpe, Umberto De Berardis, Domenico Latini, Roberto Papanti, Gabriele Duccio Corkery, John Martin Medicina (Kaunas) Review Background and Objectives: Post-traumatic stress disorder (PTSD) is a common psychiatric disorder resulting from a traumatic event, is manifested through hyperarousal, anxiety, depressive symptoms, and sleep disturbances. Despite several therapeutic approaches being available, both pharmacological and psychological, recently a growing interest has developed in using cannabis and synthetic cannabinoids stems from their consideration as more efficient and better tolerated alternatives for the treatment of this condition. The present paper aims to evaluate the clinical and therapeutic potentials of medical cannabis and synthetic cannabinoids in treating PTSD patients. Methods: A systematic electronic search was performed, including all papers published up to May 2019, using the following keywords (((cannabis[Title/Abstract]) OR (synthetic cannabinoids [Title/Abstract])) AND ((PTSD[Title/Abstract]) OR (Posttraumatic stress disorder[Title/Abstract]))) for the topics ‘Cannabis’, ‘Synthetic Cannabinoids’, ‘PTSD’, and MESH terms, on the PubMed, Cochrane Library, and Web of Science online databases. For data gathering purposes, PRISMA guidelines were followed. Results were organized into two groups, considering cannabis and synthetic cannabinoids as different therapeutic approaches for PTSD. Results: Present data show that cannabis and synthetic cannabinoids, both acting on the endocannabinoids system, may have a potential therapeutic use for improving PTSD symptoms, e.g., reducing anxiety, modulating memory-related processes, and improving sleep. Conclusions: Even though the current literature suggests that cannabis and synthetic cannabinoids may have a role in the treatment of PTSD, there is currently limited evidence regarding their safety and efficacy. Therefore, additional research is needed in order to better understand the effectiveness and therapeutic usage of these drug classes and monitor their safety. MDPI 2019-08-23 /pmc/articles/PMC6780141/ /pubmed/31450833 http://dx.doi.org/10.3390/medicina55090525 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Orsolini, Laura
Chiappini, Stefania
Volpe, Umberto
De Berardis, Domenico
Latini, Roberto
Papanti, Gabriele Duccio
Corkery, John Martin
Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review
title Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review
title_full Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review
title_fullStr Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review
title_full_unstemmed Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review
title_short Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review
title_sort use of medicinal cannabis and synthetic cannabinoids in post-traumatic stress disorder (ptsd): a systematic review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780141/
https://www.ncbi.nlm.nih.gov/pubmed/31450833
http://dx.doi.org/10.3390/medicina55090525
work_keys_str_mv AT orsolinilaura useofmedicinalcannabisandsyntheticcannabinoidsinposttraumaticstressdisorderptsdasystematicreview
AT chiappinistefania useofmedicinalcannabisandsyntheticcannabinoidsinposttraumaticstressdisorderptsdasystematicreview
AT volpeumberto useofmedicinalcannabisandsyntheticcannabinoidsinposttraumaticstressdisorderptsdasystematicreview
AT deberardisdomenico useofmedicinalcannabisandsyntheticcannabinoidsinposttraumaticstressdisorderptsdasystematicreview
AT latiniroberto useofmedicinalcannabisandsyntheticcannabinoidsinposttraumaticstressdisorderptsdasystematicreview
AT papantigabrieleduccio useofmedicinalcannabisandsyntheticcannabinoidsinposttraumaticstressdisorderptsdasystematicreview
AT corkeryjohnmartin useofmedicinalcannabisandsyntheticcannabinoidsinposttraumaticstressdisorderptsdasystematicreview